Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

[The sore throat: tonsillitis in children and adults].

Stelter K, Dellian M.

MMW Fortschr Med. 2019 Mar;161(Suppl 1):31-39. doi: 10.1007/s15006-019-0007-9. Review. German. No abstract available.

PMID:
30912061
2.

Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer.

Strieth S, Dunau C, Michaelis U, Jäger L, Gellrich D, Wollenberg B, Dellian M.

Head Neck. 2014 Jul;36(7):976-84. doi: 10.1002/hed.23397. Epub 2013 Dec 11.

PMID:
23733258
3.

Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer.

Strieth S, Dunau C, Kolbow K, Knuechel R, Michaelis U, Ledderose H, Eichhorn ME, Strelczyk D, Tschiesner U, Wollenberg B, Dellian M.

Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1481-7. doi: 10.1007/s00405-012-2185-2. Epub 2012 Sep 27.

PMID:
23015197
4.

Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.

Eichhorn ME, Ischenko I, Luedemann S, Strieth S, Papyan A, Werner A, Bohnenkamp H, Guenzi E, Preissler G, Michaelis U, Jauch KW, Bruns CJ, Dellian M.

Int J Cancer. 2010 Mar 1;126(5):1235-45. doi: 10.1002/ijc.24846.

5.

Static magnetic fields impair angiogenesis and growth of solid tumors in vivo.

Strelczyk D, Eichhorn ME, Luedemann S, Brix G, Dellian M, Berghaus A, Strieth S.

Cancer Biol Ther. 2009 Sep;8(18):1756-62. Epub 2009 Sep 17.

PMID:
19633422
6.

Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin.

Strieth S, Eichhorn ME, Werner A, Sauer B, Teifel M, Michaelis U, Berghaus A, Dellian M.

Clin Cancer Res. 2008 Jul 15;14(14):4603-11. doi: 10.1158/1078-0432.CCR-07-4738.

7.

Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment.

Eichhorn ME, Strieth S, Luedemann S, Kleespies A, Nöth U, Passon A, Brix G, Jauch KW, Bruns CJ, Dellian M.

Cancer Biol Ther. 2008 Jul;7(7):1006-13. Epub 2008 Mar 29.

PMID:
18398295
8.

Static magnetic fields induce blood flow decrease and platelet adherence in tumor microvessels.

Strieth S, Strelczyk D, Eichhorn ME, Dellian M, Luedemann S, Griebel J, Bellemann M, Berghaus A, Brix G.

Cancer Biol Ther. 2008 Jun;7(6):814-9.

PMID:
18340115
9.

Static magnetic fields affect capillary flow of red blood cells in striated skin muscle.

Brix G, Strieth S, Strelczyk D, Dellian M, Griebel J, Eichhorn ME, Andrā W, Bellemann ME.

Microcirculation. 2008 Jan;15(1):15-26.

PMID:
17952798
10.

Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes.

Strieth S, Nussbaum CF, Eichhorn ME, Fuhrmann M, Teifel M, Michaelis U, Berghaus A, Dellian M.

Int J Cancer. 2008 Jan 15;122(2):452-60.

11.

[Zenker's diverticulum treated by transoral diverticulostomy: technique and results].

Lang RA, Spelsberg FW, Naumann A, Dellian M, Jauch KW, Hüttl TP.

Zentralbl Chir. 2007 Oct;132(5):451-6. German.

PMID:
17907090
12.

Cationic lipid complexed camptothecin (EndoTAG-2) improves antitumoral efficacy by tumor vascular targeting.

Eichhorn ME, Luedemann S, Strieth S, Papyan A, Ruhstorfer H, Haas H, Michaelis U, Sauer B, Teifel M, Enders G, Brix G, Jauch KW, Bruns CJ, Dellian M.

Cancer Biol Ther. 2007 Jun;6(6):920-9. Epub 2007 Mar 26.

PMID:
17534143
13.

[Squamous cell carcinoma of the nasal vestibule].

Klemens C, Dellian M, Berghaus A.

MMW Fortschr Med. 2006 Jul 6;148(27-28):39, 41. German.

PMID:
16886488
14.

Antiangiogenic combination tumor therapy blocking alpha(v)-integrins and VEGF-receptor-2 increases therapeutic effects in vivo.

Strieth S, Eichhorn ME, Sutter A, Jonczyk A, Berghaus A, Dellian M.

Int J Cancer. 2006 Jul 15;119(2):423-31.

15.

Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imaging.

Eichhorn ME, Becker S, Strieth S, Werner A, Sauer B, Teifel M, Ruhstorfer H, Michaelis U, Griebel J, Brix G, Jauch KW, Dellian M.

Cancer Biol Ther. 2006 Jan;5(1):89-96. Epub 2006 Jan 22.

PMID:
16357513
16.

A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.

Wilkowski R, Pachmann S, Schymura B, Dellian M, Schalhorn A, Dühmke E.

Onkologie. 2005 Oct;28(10):491-5. Epub 2005 Aug 2.

PMID:
16160398
17.

[Mass in the neck--the view of the ENT specialist].

Dellian M.

MMW Fortschr Med. 2005 Mar 3;147(9):26-7, 29-30. German.

PMID:
15794350
18.

[Unexplained swelling in the neck. How thorough must the diagnostic workup be?].

Berghaus A, Dellian M.

MMW Fortschr Med. 2005 Mar 3;147(9):25. German. No abstract available.

PMID:
15794349
19.

A new animal model to assess angiogenesis and endocrine function of parathyroid heterografts in vivo.

Strieth S, von Johnston V, Eichhorn ME, Enders G, Krasnici S, Thein E, Hammer C, Dellian M.

Transplantation. 2005 Feb 27;79(4):392-400. Erratum in: Transplantation. 2005 Apr 15;79(7):859. Eichhon, Martin E [corrected to Eichhorn, Martin E].

PMID:
15729164
20.

Protamine enhances uptake of cationic liposomes in angiogenic microvessels.

Eichhorn ME, Strieth S, Krasnici S, Sauer B, Teifel M, Michaelis U, Naujoks K, Dellian M.

Angiogenesis. 2004;7(2):133-41.

PMID:
15516834
21.

Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives.

Eichhorn ME, Strieth S, Dellian M.

Drug Resist Updat. 2004 Apr;7(2):125-38. Review.

PMID:
15158768
22.

Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature.

Strieth S, Eichhorn ME, Sauer B, Schulze B, Teifel M, Michaelis U, Dellian M.

Int J Cancer. 2004 May 20;110(1):117-24.

23.

Novel temperature-sensitive liposomes with prolonged circulation time.

Lindner LH, Eichhorn ME, Eibl H, Teichert N, Schmitt-Sody M, Issels RD, Dellian M.

Clin Cancer Res. 2004 Mar 15;10(6):2168-78.

24.

Dynamic intravital fluorescence microscopy--a novel method for the assessment of microvascular permeability in acute pancreatitis.

von Dobschuetz E, Pahernik S, Hoffmann T, Kiefmann R, Heckel K, Messmer K, Mueller-Hoecker J, Dellian M.

Microvasc Res. 2004 Jan;67(1):55-63.

PMID:
14709403
25.

Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic pancreatitis in the rat.

von Dobschuetz E, Bleiziffer O, Pahernik S, Dellian M, Hoffmann T, Messmer K.

Am J Physiol Gastrointest Liver Physiol. 2004 May;286(5):G791-6. Epub 2003 Dec 23.

26.

Depressive symptoms during and after radiotherapy for head and neck cancer.

Sehlen S, Lenk M, Herschbach P, Aydemir U, Dellian M, Schymura B, Hollenhorst H, Dühmke E.

Head Neck. 2003 Dec;25(12):1004-18.

PMID:
14648859
27.

Hyperthermia induces T1 relaxation and blood flow changes in tumors. A MRI thermometry study in vivo.

Peller M, Kurze V, Loeffler R, Pahernik S, Dellian M, Goetz AE, Issels R, Reiser M.

Magn Reson Imaging. 2003 Jun;21(5):545-51.

PMID:
12878265
28.

Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.

Schmitt-Sody M, Strieth S, Krasnici S, Sauer B, Schulze B, Teifel M, Michaelis U, Naujoks K, Dellian M.

Clin Cancer Res. 2003 Jun;9(6):2335-41.

29.

Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels.

Krasnici S, Werner A, Eichhorn ME, Schmitt-Sody M, Pahernik SA, Sauer B, Schulze B, Teifel M, Michaelis U, Naujoks K, Dellian M.

Int J Cancer. 2003 Jul 1;105(4):561-7.

30.

Platelet-endothelial interaction in tumor angiogenesis and microcirculation.

Manegold PC, Hutter J, Pahernik SA, Messmer K, Dellian M.

Blood. 2003 Mar 1;101(5):1970-6.

PMID:
12584142
31.

[Antivascular strategies--a new concept for diagnosis and therapy of head and neck cancer. A review].

Dellian M, Eichhorn ME, Strieth S.

Laryngorhinootologie. 2002 Jul;81(7):509-15. Review. German.

PMID:
12173062
32.

[Clinical and epidemiological data of patients with malignomas of the head and neck].

Lang S, Wollenberg B, Dellian M, Steuer-Vogt MK, Schwenzer K, Sautier W, Chucholowski M, Eckel R, Faas I, Wilmes E, Ehrenfeld M, Arnold W, Kastenbauer E, Hölzel D.

Laryngorhinootologie. 2002 Jul;81(7):499-508. German.

PMID:
12173061
33.

Orthogonal polarisation spectral imaging as a new tool for the assessment of antivascular tumour treatment in vivo: a validation study.

Pahernik S, Harris AG, Schmitt-Sody M, Krasnici S, Goetz AE, Dellian M, Messmer K.

Br J Cancer. 2002 May 20;86(10):1622-7.

34.

Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.

Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK.

Clin Cancer Res. 2002 Apr;8(4):1284-91.

35.

Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo.

Buerkle MA, Pahernik SA, Sutter A, Jonczyk A, Messmer K, Dellian M.

Br J Cancer. 2002 Mar 4;86(5):788-95.

36.

Quantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imaging.

Pahernik S, Griebel J, Botzlar A, Gneiting T, Brandl M, Dellian M, Goetz AE.

Br J Cancer. 2001 Nov 30;85(11):1655-63.

37.

Tissue distribution and penetration of 5-ALA induced fluorescence in an amelanotic melanoma after topical application.

Pahernik S, Langer S, Botzlar A, Dellian M, Goetz AE.

Anticancer Res. 2001 Jan-Feb;21(1A):59-63.

PMID:
11299790
38.

Vascular permeability in a human tumour xenograft: molecular charge dependence.

Dellian M, Yuan F, Trubetskoy VS, Torchilin VP, Jain RK.

Br J Cancer. 2000 May;82(9):1513-8.

39.

Validation of MR thermometry technology: a small animal model for hyperthermic treatment of tumours.

Pahernik SA, Peller M, Dellian M, Loeffler R, Issels R, Reiser M, Messmer K, Goetz AE.

Res Exp Med (Berl). 1999 Oct;199(2):59-71.

PMID:
10550639
40.

Distribution and pharmacokinetics of Photofrin in human bile duct cancer.

Pahernik SA, Dellian M, Berr F, Tannapfel A, Wittekind C, Goetz AE.

J Photochem Photobiol B. 1998 Nov;47(1):58-62.

PMID:
10052154
41.
42.

Pharmacokinetics and selectivity of aminolevulinic acid-induced porphyrin synthesis in patients with cervical intra-epithelial neoplasia.

Pahernik SA, Botzlar A, Hillemanns P, Dellian M, Kirschstein M, Abels C, Korell M, Mueller-Hoecker J, Untch M, Goetz AE.

Int J Cancer. 1998 Oct 29;78(3):310-4.

43.

Endovascular catheter-delivered photodynamic therapy in an experimental response to injury model.

Gonschior P, Vogel-Wiens C, Goetz AE, Huehns TY, Breger F, Gerheuser F, Fleuchaus M, Welsch U, Sroka R, Dellian M, Lehr HA, Höfling B.

Basic Res Cardiol. 1997 Oct;92(5):310-9.

PMID:
9486352
44.
45.

Topical application of a first porphycene dye for photodynamic therapy--penetration studies in human perilesional skin and basal cell carcinoma.

Karrer S, Abels C, Szeimies RM, Bäumler W, Dellian M, Hohenleutner U, Goetz AE, Landthaler M.

Arch Dermatol Res. 1997 Feb;289(3):132-7.

PMID:
9128760
46.
47.
48.

Local photodynamic therapy reduces tissue hyperplasia in an experimental restenosis model.

Gonschior P, Gerheuser F, Fleuchaus M, Huehns TY, Goetz AE, Welsch U, Sroka R, Dellian M, Lehr HA, Höfling B.

Photochem Photobiol. 1996 Nov;64(5):758-63.

PMID:
8931372
49.

Supplemental Content

Loading ...
Support Center